Internal Medicine, Rheumatology · Green Bay, WI
NPI
1477866325
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2223 Lime Kiln Rd, Ste 1
Green Bay, WI, 54311
Phone (920) 430-8120
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
132,236 services
Medicare patients, 2024
576
Average age 72
Drug cost, 2024
$4.5M
6,439 prescriptions
Company payments, 2025
$966
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Debbie T Lim was code J3262 (injection, tocilizumab, 1 mg), 46,961 times for 25 patients. In total Debbie T Lim billed 132,236 services in 65 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 46,961 | 25 | $4.69 | $220K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 25,300 | 48 | $9.03 | $228K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 17,470 | 100 | $24.53 | $428K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 9,025 | 35 | $33.87 | $306K |
| J9312 Injection, rituximab, 10 mg | Office | 4,800 | 22 | $61.28 | $294K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,076 | 36 | $0.22 | $466 |
| J0897 Injection, denosumab, 1 mg | Office | 1,020 | 12 | $20.58 | $21K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 820 | 240 | $0.51 | $422 |
| 99214 Office E&M - Established | Office | 499 | 330 | $84.52 | $42K |
| 96413 Chemotherapy Administration | Office | 483 | 161 | $95.93 | $46K |
| 96415 Chemotherapy Administration | Office | 457 | 122 | $20.62 | $9,422 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 349 | 262 | $11.48 | $4,006 |
| 96365 Intravenous Infusion, Hydration | Office | 304 | 107 | $46.84 | $14K |
| 96375 Injection Administration | Office | 256 | 55 | $11.45 | $2,931 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 152 | 49 | $0.65 | $98.37 |
By year: 2022 $2.2M for 141,492 services; 2023 $2.1M for 143,148 services; 2024 $2.2M for 132,236 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 57 | 49 | $8.65 | $493 |
Medicare prescription drug claims, 2024
In 2024, the drug Debbie T Lim prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,291 prescriptions and refills. In total Debbie T Lim wrote 6,439 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,291 | 3,238 | 365 | $64K |
| Methotrexate Methotrexate Sodium | 975 | 2,325 | 252 | $31K |
| Prednisone Generic | 767 | 1,703 | 281 | $7,780 |
| Leflunomide Generic | 357 | 883 | 98 | $30K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 301 | 301 | 54 | $8,924 |
| Alendronate Sodium Generic | 276 | 722 | 90 | $4,016 |
| Allopurinol Generic | 214 | 572 | 55 | $2,460 |
| Tramadol Hcl Generic | 187 | 195 | 43 | $1,961 |
| Sulfasalazine Generic | 163 | 422 | 47 | $6,113 |
| Methylprednisolone Generic | 132 | 269 | 60 | $2,621 |
| Folic Acid Generic | 128 | 373 | 41 | $1,372 |
| Humira(Cf) Pen Adalimumab | 121 | 121 | 14 | $851K |
| Meloxicam Generic | 116 | 291 | 35 | $548 |
| Gabapentin Generic | 102 | 244 | 25 | $1,887 |
| Sulfasalazine Dr Sulfasalazine | 90 | 202 | 26 | $4,149 |
Brand drugs: 907 claims; generic drugs: 5,517 claims; opioid claims: 651.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Debbie T Lim $966 ($966 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $249.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.